Takara Bio Inc. (TYO:4974)

Takara Bio Statistics

Total Valuation

Takara Bio has a market cap or net worth of JPY 137.51 billion. The enterprise value is 128.35 billion.

Market Cap	137.51B
Enterprise Value	128.35B

Important Dates

The last earnings date was Wednesday, May 13, 2026.

Earnings Date	May 13, 2026
Ex-Dividend Date	n/a

Share Statistics

Takara Bio has 120.42 million shares outstanding.

Current Share Class	120.42M
Shares Outstanding	120.42M
Shares Change (YoY)	n/a
Shares Change (QoQ)	-0.00%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	7.06%
Float	14.30M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.41
PB Ratio	1.32
P/TBV Ratio	1.74
P/FCF Ratio	n/a
P/OCF Ratio	38.39
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 202.76, with an EV/FCF ratio of -14.27.

EV / Earnings	-13.37
EV / Sales	3.18
EV / EBITDA	202.76
EV / EBIT	n/a
EV / FCF	-14.27

Financial Position

The company has a current ratio of 5.76, with a Debt / Equity ratio of 0.11.

Current Ratio	5.76
Quick Ratio	4.01
Debt / Equity	0.11
Debt / EBITDA	17.35
Debt / FCF	-1.22
Interest Coverage	-8.05

Financial Efficiency

Return on equity (ROE) is -8.69% and return on invested capital (ROIC) is -5.04%.

Return on Equity (ROE)	-8.69%
Return on Assets (ROA)	-2.26%
Return on Invested Capital (ROIC)	-5.04%
Return on Capital Employed (ROCE)	-3.72%
Weighted Average Cost of Capital (WACC)	6.49%
Revenue Per Employee	22.66M
Profits Per Employee	-5.40M
Employee Count	1,779
Asset Turnover	0.31
Inventory Turnover	1.67

Taxes

In the past 12 months, Takara Bio has paid 353.00 million in taxes.

Income Tax	353.00M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +44.37% in the last 52 weeks. The beta is 0.44, so Takara Bio's price volatility has been lower than the market average.

Beta (5Y)	0.44
52-Week Price Change	+44.37%
50-Day Moving Average	1,143.44
200-Day Moving Average	967.93
Relative Strength Index (RSI)	55.27
Average Volume (20 Days)	294,225

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Takara Bio had revenue of JPY 40.32 billion and -9.60 billion in losses. Loss per share was -79.72.

Revenue	40.32B
Gross Profit	20.26B
Operating Income	-4.69B
Pretax Income	-9.20B
Net Income	-9.60B
EBITDA	633.00M
EBIT	-4.69B
Loss Per Share	-79.72

Balance Sheet

The company has 20.45 billion in cash and 10.98 billion in debt, with a net cash position of 9.47 billion or 78.63 per share.

Cash & Cash Equivalents	20.45B
Total Debt	10.98B
Net Cash	9.47B
Net Cash Per Share	78.63
Equity (Book Value)	103.97B
Book Value Per Share	860.89
Working Capital	37.09B

Cash Flow

In the last 12 months, operating cash flow was 3.58 billion and capital expenditures -12.58 billion, giving a free cash flow of -8.99 billion.

Operating Cash Flow	3.58B
Capital Expenditures	-12.58B
Depreciation & Amortization	5.32B
Net Borrowing	9.95B
Free Cash Flow	-8.99B
FCF Per Share	-74.68

Margins

Gross margin is 50.25%, with operating and profit margins of -11.63% and -23.81%.

Gross Margin	50.25%
Operating Margin	-11.63%
Pretax Margin	-22.82%
Profit Margin	-23.81%
EBITDA Margin	1.57%
EBIT Margin	-11.63%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 17.00, which amounts to a dividend yield of 1.49%.

Dividend Per Share	17.00
Dividend Yield	1.49%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	1.49%
Earnings Yield	-6.98%
FCF Yield	-6.54%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on March 29, 2011. It was a forward split with a ratio of 400.

Last Split Date	Mar 29, 2011
Split Type	Forward
Split Ratio	400

Scores

Takara Bio has an Altman Z-Score of 3.09 and a Piotroski F-Score of 2.

Altman Z-Score	3.09
Piotroski F-Score	2